{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:46:36Z","timestamp":1787701596861,"version":"build-2784847793"},"reference-count":41,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"published-print":{"date-parts":[[2024,12,19]]},"abstract":"<jats:p> Starting in the early 2000s, the rate of infectious syphilis in Canada began rising. Since the mid-2010s, the rate among females, particularly females in their reproductive years, has increased rapidly. Coincident with this shift, congenital syphilis has re-emerged in Canada in recent years. Infectious and congenital syphilis disproportionately impact communities affected by social and structural determinants of health, including homelessness and inadequate or inaccessible health care services. These realities underscore the importance of emerging strategies, including rapid diagnostic tests that can be deployed at the point of care, as tools to help reverse these trends. Increased access to testing is one of the pillars of the Pan-Canadian Framework for Action on Sexually Transmitted and Blood-Borne Infections (STBBI) and the Government of Canada's STBBI Action Plan 2024\u20132030. The National Microbiology Laboratory Branch of the Public Health Agency of Canada has worked towards introducing rapid diagnostic tests including point-of-care tests (POCTs) for STBBI testing. With Health Canada's first approval of a syphilis POCT (bioLytical's INSTI MULTIPLEX HIV-1\/2 Syphilis Ab Test) in 2023, it is timely to reflect on important implementation considerations for this and other syphilis POCTs in Canada. In this article, we aim to review antibody-detecting syphilis POCTs that are commercially available, their performance in recent Canadian field studies, and key contextual considerations for Canada in implementing POCTs for syphilis. <\/jats:p>","DOI":"10.3138\/jammi-2024-0008","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T15:32:09Z","timestamp":1734622329000},"page":"208-218","source":"Crossref","is-referenced-by-count":2,"title":["Syphilis point-of-care tests (POCTs): Implementation considerations in Canada"],"prefix":"10.3138","volume":"9","author":[{"given":"Kathleen","family":"Whyte","sequence":"first","affiliation":[{"name":"Laboratory for Syphilis Diagnostics, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Chittle","sequence":"additional","affiliation":[{"name":"Sexually Transmitted and Blood-Borne Infections Surveillance Division, Public Health Agency of Canada, Guelph, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond SW","family":"Tsang","sequence":"additional","affiliation":[{"name":"Laboratory for Syphilis Diagnostics, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"},{"name":"Correspondence: Raymond SW Tsang, 1015 Arlington Street, Winnipeg, Manitoba, R3E 3R2 Canada. Telephone: 204-789-6020."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1696","reference":[{"issue":"6","key":"r1","first-page":"1","volume":"23","author":"Health Canada","year":"1997","journal-title":"Can Commun Dis Rep"},{"issue":"2","key":"r2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.14745\/ccdr.v48i23a01","volume":"48","author":"Aho J","year":"2022","journal-title":"Can Commun Dis Rep"},{"key":"r3","unstructured":"Centers for Disease Control and Prevention. National overview \u2013 sexually transmitted disease surveillance, 2019. 2021; https:\/\/www.cdc.gov\/std\/statistics\/2019\/std-surveillance-2019.pdf. Accessed November 6, 2023."},{"key":"r4","unstructured":"Kirby Institute, University of South Wales. Sexually transmissible infections. https:\/\/data.kirby.unsw.edu.au\/STIs. Accessed: November 6, 2023."},{"issue":"10","key":"r5","first-page":"439","volume":"49","author":"Public Health Agency of Canada","year":"2023","journal-title":"Can Commun Dis Rep"},{"key":"r6","volume-title":"Tracking the syphilis epidemic in England, 2010 to 2019","author":"Public Health England","year":"2021"},{"issue":"7","key":"r7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.14745\/ccdr.v44i78a05","volume":"44","author":"Centre for Communicable Diseases and Infection Control","year":"2018","journal-title":"Can Commun Dis Rep"},{"key":"r8","unstructured":"Government of Canada. Government of Canada's sexually transmitted and blood-borne infections (STBBI) action plan 2024-2030. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/sexually-transmitted-blood-borne-infections-action-plan-2024-2030.html. Accessed July 26, 2024."},{"key":"r9","unstructured":"World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. Geneva: World Health Organization, 2022; https:\/\/iris.who.int\/bitstream\/handle\/10665\/360348\/9789240053779-eng.pdf?sequence=1. Accessed August 9, 2024."},{"key":"r10","unstructured":"Public Health Agency of Canada. Public health risk profile: infectious syphilis outbreaks and re-emergence of congenital syphilis in Canada. 2023; https:\/\/www.canada.ca\/en\/public-health\/services\/emergency-preparedness-response\/rapid-risk-assessments-public-health-professionals\/risk-profile-infectious-syphilis-outbreaks-emergence-congenital-syphilis.html. Accessed December 8, 2023."},{"key":"r11","first-page":"2865","volume-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","author":"Radolf JD","year":"2020","edition":"9"},{"key":"r12","doi-asserted-by":"publisher","DOI":"10.3138\/jammi-2022-0015"},{"issue":"1","key":"r13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.8.1.1","volume":"8","author":"Larsen SA","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"r14","unstructured":"Public Health Agency of Canada. Syphilis guide: screening and diagnostic testing. 2023; https:\/\/www.canada.ca\/en\/public-health\/services\/infectious-diseases\/sexual-health-sexually-transmitted-infections\/canadian-guidelines\/syphilis\/screening-diagnostic-testing.html. Accessed November 6, 2023."},{"key":"r15","doi-asserted-by":"publisher","DOI":"10.3138\/jammi-2021-0021"},{"key":"r16","unstructured":"World Health Organization. The diagnostic landscape for sexually transmitted infections. 2023; https:\/\/iris.who.int\/bitstream\/handle\/10665\/371498\/9789240077126-eng.pdf?sequence=1. Accessed November 22, 2023."},{"issue":"5","key":"r17","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/sti.2006.024265","volume":"82","author":"Peeling RW","year":"2006","journal-title":"Sex Transm Infect"},{"issue":"1","key":"r18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41564-018-0295-3","volume":"4","author":"Land KJ","year":"2019","journal-title":"Review Nat Microbiol"},{"issue":"7","key":"r19","doi-asserted-by":"crossref","first-page":"940.e1","DOI":"10.1016\/j.cmi.2023.02.015","volume":"29","author":"Singh AE","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"r20","doi-asserted-by":"crossref","first-page":"1335.e1","DOI":"10.1016\/j.cmi.2023.06.013","volume":"29","author":"Caya C","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"r21","doi-asserted-by":"crossref","first-page":"100440","DOI":"10.1016\/j.eclinm.2020.100440","volume":"24","author":"Pham MD","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"1","key":"r22","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1093\/cid\/ciaa350","volume":"71","author":"Bristow CC","year":"2020","journal-title":"Clin Infect Dis"},{"key":"r23","unstructured":"National Syphilis and Congenital Syphilis Syndemic Federal Task Force. Considerations for the implementation of point-of-care (POC) tests for syphilis. June 2024; https:\/\/www.hhs.gov\/sites\/default\/files\/nscss-considerations-for-the-implementation-of-syphilis-poc-tests.pdf. Accessed July 31, 2024."},{"key":"r24","doi-asserted-by":"crossref","unstructured":"Maliszewski KN, Hsieh Y, Curbeam D, An evaluation of the performance, patient acceptability and feasibility of a point-of-care HIV-syphilis assay in an urban emergency department. Sex Transm Dis. 2024;51(10):648\u201353. https:\/\/doi.org\/10.1097\/OLQ.0000000000001995. PMID: 38722756","DOI":"10.1097\/OLQ.0000000000001995"},{"key":"r25","doi-asserted-by":"crossref","unstructured":"Mackrell L, Carter M, Hoover M, The syphilis point of care rapid testing and immediate treatment evaluation (SPRITE) study. medRxiv, posted May 25, 2024. https:\/\/www.medrxiv.org\/content\/10.1101\/2024.05.24.24307902v1. Accessed July 31, 2024. https:\/\/doi.org\/10.1101\/2024.05.24.24307902","DOI":"10.1101\/2024.05.24.24307902"},{"key":"r26","doi-asserted-by":"crossref","unstructured":"Bitnun A, Sauv\u00e9 L, Fanella S. Reducing perinatal infection risk in newborns of mothers who received inadequate prenatal care. https:\/\/cps.ca\/en\/documents\/position\/reducing-perinatal-infection-risk-in-newborns-of-mothers-who-received-inadequate-prenatal-care. Accessed August 30, 2024. https:\/\/doi.org\/10.1093\/pch\/pxad014. PMID: 37484040","DOI":"10.1093\/pch\/pxad014"},{"issue":"2","key":"r27","first-page":"82","volume":"48","author":"Tsang RSW","year":"2022","journal-title":"Can Commun Dis Rep"},{"issue":"8","key":"r28","doi-asserted-by":"crossref","first-page":"e0201622","DOI":"10.1371\/journal.pone.0201622","volume":"13","author":"Vernelen K","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"r29","doi-asserted-by":"crossref","first-page":"e2210559","DOI":"10.1001\/jamanetworkopen.2022.10559","volume":"5","author":"Papenburg J","year":"2022","journal-title":"JAMA Netw Open"},{"key":"r30","volume-title":"Selection Criteria for Point-of-Care Testing Devices; Approved Guideline. CLSI document POCT09-A","author":"Clinical and Laboratory Standards Institute","year":"2010"},{"key":"r31","unstructured":"Public Health Agency of Canada. Syphilis guide: treatment and follow-up. 2023; https:\/\/www.canada.ca\/en\/public-health\/services\/infectious-diseases\/sexual-health-sexually-transmitted-infections\/canadian-guidelines\/syphilis\/treatment-follow-up.html. Accessed November 22, 2023."},{"issue":"4","key":"r32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"Workowski KA","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"r33","volume-title":"Development and implementation of a training system for syphilis point-of-care testing in primary care settings. Poster presentation at the Australian Conference on Point-of-Care Testing for Infectious Diseases","author":"Rivers-Kennedy A","year":"2023"},{"key":"r34","first-page":"100845","volume":"37","author":"Xia Y","year":"2024","journal-title":"Lancet Reg Health Am"},{"issue":"5","key":"r35","first-page":"1","volume":"9","author":"Hui BB","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"r36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s43058-021-00232-8","volume":"2","author":"Lafferty L","year":"2021","journal-title":"BMC Implement Sci Commun"},{"key":"r37","doi-asserted-by":"crossref","first-page":"e035838","DOI":"10.1136\/bmjopen-2019-035838","volume":"10","author":"Osbak KK","year":"2020","journal-title":"BMJ Open"},{"issue":"14","key":"r38","doi-asserted-by":"crossref","first-page":"e1900244","DOI":"10.1002\/adhm.201900244","volume":"8","author":"Jiang N","year":"2019","journal-title":"Review Adv Healthc Mater"},{"key":"r39","doi-asserted-by":"crossref","first-page":"15587","DOI":"10.1021\/acs.analchem.0c03740","volume":"92","author":"Ross GMS","year":"2020","journal-title":"Anal Chem"},{"key":"r40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1471-2334-12-353","volume":"12","author":"Shields M","year":"2012","journal-title":"BMC Infect Dis"},{"key":"r41","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1039\/D2LC00242F","volume":"22","author":"Malic L","year":"2022","journal-title":"Lab Chip"}],"container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/jammi-2024-0008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T15:32:47Z","timestamp":1734622367000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/jammi-2024-0008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12,19]]}},"alternative-id":["10.3138\/jammi-2024-0008"],"URL":"https:\/\/doi.org\/10.3138\/jammi-2024-0008","relation":{},"ISSN":["2371-0888"],"issn-type":[{"value":"2371-0888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]}}}